login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
All US stocks
All Canadian stocks
All European stocks
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Account
Disclaimer
Affiliate
Contact
Privacy
ADC THERAPEUTICS SA (ADCT) Stock News
NYSE:ADCT -
CH0499880968
-
Common Stock
3.235
USD
+0.01 (+0.47%)
Last: 8/28/2025, 3:57:55 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
ADCT Latest News, Press Relases and Analysis
All
Press Releases
9 hours ago - By: Benzinga
- Mentions:
SPY
QQQ
CLLS
HOTH
...
Top 5 Biotech Stocks With Strong Momentum
a day ago - By: ADC Therapeutics SA
ADC Therapeutics to Present at the Cantor Global Healthcare Conference 2025
16 days ago - By: Zacks Investment Research
- Mentions:
ALVO
ADC Therapeutics SA (ADCT) Reports Q2 Loss, Tops Revenue Estimates
16 days ago - By: ADC Therapeutics SA
ADC Therapeutics Reports Second Quarter 2025 Financial Results and Provides Operational Update
17 days ago - By: Zacks Investment Research
- Mentions:
TELA
TELA Bio, Inc. (TELA) Reports Q2 Loss, Lags Revenue Estimates
17 days ago - By: Benzinga
Preview: ADC Therapeutics's Earnings
21 days ago - By: Zacks Investment Research
- Mentions:
ETON
Eton Pharmaceuticals, Inc. (ETON) Reports Q2 Loss, Tops Revenue Estimates
23 days ago - By: ADC Therapeutics SA
ADC Therapeutics to Host Second Quarter 2025 Financial Results Conference Call on August 12, 2025
24 days ago - By: Zacks Investment Research
- Mentions:
ALNY
Are Medical Stocks Lagging ADC Therapeutics (ADCT) This Year?
a month ago - By: ADC Therapeutics SA
ADC Therapeutics Makes Grants to New Employees Under Inducement Plan
2 months ago - By: ADC Therapeutics SA
ADC Therapeutics Makes Grant to New Employee Under Inducement Plan
2 months ago - By: ADC Therapeutics SA
ADC Therapeutics Announces Updated ZYNLONTA® Investigator-Initiated Trial Data in R/R Marginal Zone Lymphoma Presented at 18th International Conference on Malignant Lymphoma (ICML)
3 months ago - By: ADC Therapeutics SA
ADC Therapeutics Announces $100 Million Private Placement Extending Expected Cash Runway into 2028
3 months ago - By: ADC Therapeutics SA
ADC Therapeutics Announces Updated Data from LOTIS-7 Clinical Trial Presented at the European Hematology Association 2025 Congress
3 months ago - By: ADC Therapeutics SA
ADC Therapeutics Makes Grants to New Employees Under Inducement Plan
3 months ago - By: Yahoo Finance
- Mentions:
AMAT
WMT
ENTA
ARCT
...
AMAT Earnings: Demand Holding Up So Far
4 months ago - By: ADC Therapeutics SA
ADC Therapeutics to Present at Upcoming Investor Conferences
4 months ago - By: Zacks Investment Research
- Mentions:
ARMP
ADC Therapeutics SA (ADCT) Reports Q1 Loss, Tops Revenue Estimates
4 months ago - By: ADC Therapeutics SA
ADC Therapeutics Reports First Quarter 2025 Financial Results and Provides Operational Update
4 months ago - By: ADC Therapeutics SA
ADC Therapeutics Announces Presentation of LOTIS-7 Clinical Trial Data at the European Hematology Association 2025 Congress (EHA2025) and the 18th International Conference on Malignant Lymphoma (ICML)
4 months ago - By: Zacks Investment Research
- Mentions:
ZYME
Zymeworks Inc. (ZYME) Reports Q1 Loss, Tops Revenue Estimates
4 months ago - By: ADC Therapeutics SA
ADC Therapeutics to Host First Quarter 2025 Financial Results Conference Call on May 14, 2025
4 months ago - By: Zacks Investment Research
- Mentions:
KURA
Kura Oncology (KURA) Reports Q1 Loss, Lags Revenue Estimates
4 months ago - By: Zacks Investment Research
- Mentions:
AGEN
Agenus (AGEN) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
4 months ago - By: Zacks Investment Research
- Mentions:
CRDF
ADC Therapeutics SA (ADCT) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
5 months ago - By: ADC Therapeutics SA
ADC Therapeutics Makes Grants to New Employees Under Inducement Plan
5 months ago - By: ADC Therapeutics SA
ADC Therapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference
5 months ago - By: Zacks Investment Research
- Mentions:
KNSA
ADC Therapeutics SA (ADCT) Reports Q4 Loss, Misses Revenue Estimates
5 months ago - By: ADC Therapeutics SA
ADC Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Operational Update
5 months ago - By: ADC Therapeutics SA
ADC Therapeutics Announces Abstracts Accepted for Presentation at the American Association for Cancer Research Annual Meeting 2025
Please enable JavaScript to continue using this application.